Blog dermatologico

Elenco degli articoli con argomento «FDA»

Italian guidelines in diagnosis and treatment of alopecia areata

Italian guidelines in diagnosis and treatment of alopecia areata

Ricerca

Alopecia Areata (AA) is an organ-specific autoimmune disorder that targets anagen phase hair follicles....

Leggi tutto
Psoriasi a placche, Fda approva farmaco per l'uso negli adolescenti dai 12 anni di età

Psoriasi a placche, Fda approva farmaco per l'uso negli adolescenti dai 12 anni di età

Rassegna stampa

La Food and Drug Administration (FDA) degli Stati Uniti ha approvato calcipotriene 0,005% formulato in schiuma, commercializzato da Mayne Pharma Group, per il trattamento della psoriasi a placche del cuoio capelluto e del corpo negli a...

Leggi tutto
Brexit, anche la Fda si sposta da Londra ad Amsterdam

Brexit, anche la Fda si sposta da Londra ad Amsterdam

Rassegna stampa

Non è escluso che gli uffici di rappresentanza della Food and drug administration nel Regno Unito si spostino in Olanda per mantenere la vicinanza con Ema...

Leggi tutto
Dermatite atopica, ecco le prospettive di trattamento più promettenti

Dermatite atopica, ecco le prospettive di trattamento più promettenti

Rassegna stampa

Studi clinici hanno mostrato che l’uso di anticorpi monoclonali riesce a ridurre i gravi effetti di questa malattia cronica della pelle...

Leggi tutto
FDA Approves Dupilumab Injection for Atopic Dermatitis

FDA Approves Dupilumab Injection for Atopic Dermatitis

Rassegna stampa

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) injection to treat adults with moderate-to-severe atopic dermatitis....

Leggi tutto
FDA Approves Avelumab for Metastatic Merkel Cell Carcinoma

FDA Approves Avelumab for Metastatic Merkel Cell Carcinoma

Rassegna stampa

The US Food and Drug Administration (FDA) has granted accelerated approval to avelumab (Bavencio) for the treatment of patients aged 12 years and older with metastatic Merkel cell carcinoma (MCC)....

Leggi tutto
FDA Approves Pembrolizumab for Certain Patients With Hodgkin Lymphoma

FDA Approves Pembrolizumab for Certain Patients With Hodgkin Lymphoma

Rassegna stampa

The US Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab (Keytruda) for the treatment of adult and paediatric patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after 3 ...

Leggi tutto
Topical Oxymetazoline 1.0% Shows Long-Term Efficacy for Persistent Facial Erythema Associated With Rosacea

Topical Oxymetazoline 1.0% Shows Long-Term Efficacy for Persistent Facial Erythema Associated With Rosacea

Rassegna stampa

Patients were able to tolerate treatment of their rosacea with topical 1% oxymetazoline hydrochloride gel for 1 year with acceptable reduction of redness and few adverse events, according to a study presented here at the 75th Annual Me...

Leggi tutto
FDA Approves Brodalumab to Treat Psoriasis

FDA Approves Brodalumab to Treat Psoriasis

Rassegna stampa

The US Food and Drug Administration (FDA) has approved brodalumab (Siliq) to treat adults with moderate-to-severe plaque psoriasis. Brodalumab is administered as an injection....

Leggi tutto
FDA Approves Crisaborole to Treat Atopic Dermatitis

FDA Approves Crisaborole to Treat Atopic Dermatitis

Rassegna stampa

The US Food and Drug Administration (FDA) has approved crisaborole (Eucrisa) ointment to treat atopic dermatitis in patients aged 2 years and older....

Leggi tutto
FDA Evaluating the Risk of Burns, Scars With Sumatriptan Migraine Patch

FDA Evaluating the Risk of Burns, Scars With Sumatriptan Migraine Patch

Rassegna stampa

The US Food and Drug Administration (FDA) is investigating the risk of serious burns and potential permanent scarring with the use of sumatriptan iontophoretic transdermal system patch (Zecuity) for migraine headaches...

Leggi tutto
Fda approva reslizumab nel trattamento dell'asma grave

Fda approva reslizumab nel trattamento dell'asma grave

Rassegna stampa

La Food and Drug Administration (Fda) ha autorizzato l'uso di reslizumab nella terapia di mantenimento dell'asma grave in soggetti di 18 anni e più già in trattamento con altri farmaci...

Leggi tutto
FDA Approves Ixekizumab for Adults With Plaque Psoriasis

FDA Approves Ixekizumab for Adults With Plaque Psoriasis

Rassegna stampa

The US Food and Drug Administration (FDA) has approved ixekizumab (Taltz) for the treatment of adults with moderate-to-severe plaque psoriasis...

Leggi tutto
FDA Approves Nivolumab for Patients With BRAF V600 Wild-Type Advanced Melanoma

FDA Approves Nivolumab for Patients With BRAF V600 Wild-Type Advanced Melanoma

Rassegna stampa

The US Food and Drug Administration (FDA) has granted accelerated approval to nivolumab (Opdivo) in combination with ipilimumab for the treatment of patients with BRAF V600 wild-type, unresectable or metastatic melanoma...

Leggi tutto
Methylphenidate Transdermal System May Cause Chemical Leukoderma, Warns FDA

Methylphenidate Transdermal System May Cause Chemical Leukoderma, Warns FDA

Rassegna stampa

The US Food and Drug Administration (FDA) is warning that chemical leukoderma may occur with use of the methylphenidate transdermal system (Daytrana patch) for attention-deficit/hyperactivity disorder...

Leggi tutto
Blood Test for Patients on Acne Medication Deemed Unnecessary

Blood Test for Patients on Acne Medication Deemed Unnecessary

Rassegna stampa

For young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense...

Leggi tutto
Melanoma. Nivolumab: il farmaco riceve l'approvazione accelerata dalla FDA

Melanoma. Nivolumab: il farmaco riceve l'approvazione accelerata dalla FDA

Rassegna stampa

La Food and Drug Administration (FDA - Agenzia per gli Alimenti e i Medicinali), l'ente regolatorio statunitense, ha fornito un'approvazione accelerata al farmaco Nivolumab, di Bristol-Myers Squibb, per uso endovenoso. L'accelerazione ...

Leggi tutto
Nivolumab for Advanced Melanoma

Nivolumab for Advanced Melanoma

Rassegna stampa

The US Food and Drug Administration (FDA) today approved nivolumab (Opdivo) for the treatment of patients with unresectable or metastatic melanoma who no longer respond to other drugs...

Leggi tutto
FDA Warns of Rare But Potentially Fatal Skin Reactions With Use of Ziprasidone

FDA Warns of Rare But Potentially Fatal Skin Reactions With Use of Ziprasidone

Rassegna stampa

The US Food and Drug Administration (FDA) is warning healthcare professionals that the antipsychotic drug ziprasidone (Geodon) is associated with a rare but serious skin reaction that can progress to affect other parts of the body...

Leggi tutto
Al via libera FDA a trattamento Celgene per psoriasi a placche

Al via libera FDA a trattamento Celgene per psoriasi a placche

Rassegna stampa

L'agenzia statunitense Food and Drug Administration (Fda) ha approvato apremilast, l'inibitore selettivo orale della fosfodiesterasi 4 (Pde4) sviluppato da Celgene Corporation per il trattamento della psoriasi a placche da moderata a g...

Leggi tutto

Risultati da 1 a 20 di 28